PCOS Renamed PMOS: What the New Name Means for Women in India

PCOS Is Now Called PMOS, But Don’t Panic. Here’s What Actually Matters.

PCOS (Polycystic Ovary Syndrome) has been officially renamed PMOS (Polyendocrine Metabolic Ovarian Syndrome) following a 14-year global research initiative published in The Lancet (May 2026). The condition itself has not changed; only the name has. The most clinically significant feature of PMOS remains what it always was: ovulatory dysfunction. Here’s what this means for you.

What Is PMOS? And Is It Different From PCOS? 

PMOS, which means Polyendocrine Metabolic Ovarian Syndrome, is not a new condition. It is the same condition you may have known as PCOS, with a name that more accurately reflects what is actually happening in the body.

The new name, Polyendocrine Metabolic Ovarian Syndrome, breaks down like this:

The condition affects more than 170 million women worldwide – more than one in eight – making it one of the most common hormonal disorders among women of reproductive age (Teede HJ et al., The Lancet, 2026).

In India specifically, PCOS/PMOS prevalence is estimated at 1 in 5 women of reproductive age, significantly higher than the global average, according to data published by the Indian Council of Medical Research (ICMR, 2023).

If you have already been diagnosed with PCOS, your diagnosis is still valid. 

Why Was the Name Changed? 

The renaming came after 14 years of coordinated global research across six continents, led by Professor Helena Teede at Monash University in Melbourne, Australia.

The core problem with the old name was that it was scientifically inaccurate. Research confirmed that there is no pathological increase in abnormal ovarian cysts in women with this condition. The follicles seen on ultrasound are not true cysts in the clinical sense. Calling them “polycystic” has, for decades, sent both patients and clinicians down the wrong diagnostic path.

The name PCOS also created an overfocus on the ovaries, when the condition is driven by a broader hormonal disruption involving insulin, androgens, and the hypothalamic-pituitary axis. This contributed to:

• Delayed or missed diagnoses
• Fragmented care across specialities
• Patients are not being screened for metabolic comorbidities
• Inadequate understanding of long-term health implications

The new name was chosen to be scientifically accurate, culturally appropriate across diverse populations, and easier to communicate for both clinicians and patients.

The renaming process involved over 22,000 patients, clinicians, and researchers worldwide across six continents before consensus was reached, according to (Teede HJ et al., The Lancet, 2026).

PCOS vs PMOS: What’s the Difference?

There is no clinical difference between PCOS and PMOS. The table below summarises what changed and what stayed the same:

Should You Be Worried About the New Name? 

This is a fair concern, and it deserves a direct answer: No.

The name change can sound alarming at first. Words like “polyendocrine” and “metabolic” may feel heavier than “polycystic.” And if you were already confused about the difference between PCOS and PCOD, which many women are, adding PMOS into the picture can feel overwhelming.

It’s completely understandable to feel that way. Many women have shared the same reaction.

But here is what’s important to hold onto: the condition has not become more serious because it has a new name. Science has simply caught up with the reality of what the condition involves. This is a correction, not an escalation.

The three-year transition period (2026–2028) is designed specifically to support patients and clinicians through the shift, with a full guideline update expected in 2028.

What Is the Most Important Factor in PMOS? 

This question matters more than the name change itself.

Despite everything that PMOS involves, insulin resistance, androgen excess, metabolic disruption, skin changes, weight fluctuations, and mood impacts, the most clinically central feature of this condition, the one that brings the majority of women into clinical care, is anovulation(irregular or absent ovulation). Disrupted periods. Difficulty conceiving.

Women don’t typically walk into a clinic saying, “I think I have insulin resistance.” They come in because their cycles are irregular. Because they’re trying to conceive, and something isn’t working. Because their period has been unpredictable for years. Because ovulation isn’t happening the way it should.

Anovulatory infertility is one of the leading reasons women with PMOS seek medical care. And it remains the most actionable, most trackable, and most treatable aspect of the condition for the majority of patients.

The Risk of Shifting Focus Away From Anovulation 

Here is where clinicians and patients alike need to pay careful attention.

The broader, more medically comprehensive framing of PMOS is scientifically justified. Metabolic health, insulin sensitivity, androgen levels – these are all real, important parts of the condition that deserve clinical attention. 

But there is a real risk that comes with a name that sounds more complex and more systemic: it can shift focus away from anovulation – the core issue – toward a cascade of supplementation, medication, and expensive interventions that may not be the most appropriate first step for every patient.

Women who receive an expanded diagnosis framed around metabolic syndrome may feel that they are carrying a much larger, more frightening condition than they thought. That fear can lead to:

• Accepting aggressive treatment protocols that are not evidence-based for their specific presentation
• Taking 10 to 12 supplements a day, many of which are not well-studied for PMOS specifically
• Spending significantly on treatments that address secondary features while the central issue – ovulation – goes under-managed
• Increased anxiety that itself worsens hormonal balance

This is not a hypothetical concern. Clinicians with long experience treating PCOS – now PMOS – have seen it happen. The label changes the way women understand their bodies, and that understanding shapes the decisions they make.

What Are the PMOS Diagnostic Criteria?

The diagnostic criteria for PMOS are the same as those previously used for PCOS. The Rotterdam criteria (2003) require at least two of the following three features: oligo-ovulation or anovulation, hyperandrogenism (clinical or biological), and polycystic ovaries on ultrasound.

In practical terms, this means:

1. Oligo-ovulation or anovulation – irregular or absent ovulation, typically fewer than 8 cycles per year 

2. Hyperandrogenism – elevated androgens confirmed by blood test, or clinical signs such as excess hair growth (hirsutism) or acne 

3. Polycystic ovarian morphology on ultrasound – 20 or more follicles per ovary, or ovarian volume greater than 10 mL

Anovulation, meaning irregular or absent ovulation, remains the most important clinical feature. If you were previously diagnosed with PCOS, your diagnosis is still valid under the new name. No re-diagnosis is required.

How Is PMOS Diagnosed?

PMOS is diagnosed using the same Rotterdam criteria used for PCOS. A diagnosis requires at least 2 of the 3 features listed above. Your doctor may use a combination of:

• Blood tests: LH, FSH, total and free testosterone, DHEAS, fasting insulin, and fasting glucose 
• Pelvic ultrasound: to assess follicle count and ovarian volume
•  Cycle history: tracking menstrual regularity over 3 or more months

What Actually Helps: A Clinician’s Perspective 

For the majority of women with PMOS, the most effective interventions are not the most expensive ones.

Clinicians who have treated this condition for years consistently find that the following have measurable, meaningful impact on ovulatory function and overall outcomes:

• Weight management –  even modest reductions in body weight (5–10%) can restore ovulation in women with PMOS-related anovulation
• Sleep quality – poor sleep disrupts cortisol and insulin regulation, both of which affect ovulatory cycles
• Stress reduction – chronic stress elevates cortisol, which suppresses reproductive hormones
• Targeted, evidence-based supplementation – not a blanket protocol of multiple supplements, but specific support for ovulatory health where indicated

The goal is not to treat a label. The goal is to restore or support ovulation, regulate the cycle, and – for women who are trying to conceive – identify and time the fertile window.

Whatever you call the condition, PCOS, PCOD, or PMOS, that goal remains the same.

How Premom Can Support You with PMOS

Understanding your cycle is one of the most empowering things you can do when managing PMOS, and that’s exactly where Premom helps.

Because anovulation is central to PMOS, tracking ovulation is the most practical, accessible tool available. Premom gives you real data, not guesswork.

With Premom, you can:

• Track OPK (ovulation predictor kit) results – Premom reads Easy@Home OPK strips and quantifies your LH level from 0 to 80 mIU/mL, giving you a numerical value rather than a simple positive/negative result. This is especially useful for women with PMOS, who may have irregular LH surges or multiple peaks – research shows LH surge patterns can be spiking, biphasic, or plateau, and that gradual-onset surges occur in over 57% of cycles. 
• Track BBT (basal body temperature) –  BBT tracking can help you understand whether ovulation actually occurred. 
• Monitor cervical mucus changes – alongside OPK and BBT, cervical mucus is a key fertility sign that Premom helps you log and interpret.
• Identify cycle patterns over time – irregular cycles are common in PMOS. Research shows that in only about 30% of women does the fertile window fall within the days predicted by standard clinical guidelines, even among those with regular cycles. Tracking over multiple cycles helps reveal your individual pattern, which you can share with your healthcare provider. 

PCOS has a new name, PMOS and with it comes a clearer, more accurate understanding of what your body is actually doing. The most important thing remains the same: know your cycle, trust your data, and take it one step at a time.

Read How to Track Ovulation with PMOS to see how LH, BBT, and cervical mucus work together for irregular cycles. If you want eyes on your actual data, book a virtual consultation with one of our fertility experts, or download the Premom app and start tracking today.

Track Your Cycle with PCOS/ PMOS Using Premom PRO

With PMOS, cycles are often irregular, and LH patterns can be unpredictable, which makes tracking more important, not less. A single test or a standard cycle calendar is rarely enough. What works is consistent, multi-signal tracking over time. 

With the Premom ovulation tracker app, you can scan ovulation test results, log BBT basal body temperature, and track symptoms on a single chart. Over multiple cycles, this helps you and your doctor see whether ovulation is occurring, when it tends to happen, and how your hormones are behaving across your cycle.

For irregular cycles, Premom also offers PCOS Pro, a 6-month pass designed for more complex cycle tracking. It is a one-time purchase and does not auto-renew.

PCOS Pro includes

• Tools for irregular cycle tracking
• Daily logs for sleep, PCOS diet, and stress
• Cycle insights that build over time
• PCOS-focused educational guidance
• Tracking LH, BBT, and PdG together

If cycles feel confusing, you may also consider connecting 1:1 with a Premom expert for a virtual consultation to review your tracking data and discuss next steps.

Key Takeaways

• PMOS is the same condition as PCOS; the name changed, not the diagnosis.
• Research states the old name was causing missed diagnoses and an overfocus on the ovaries, when the condition is really a broader hormonal and metabolic disorder. 
• Anovulation remains the most important clinical factor; it’s what brings most women to care and what deserves the most focus.
• A more complex name does not mean a more complex treatment. Simple interventions like weight management, sleep, and stress reduction still have the greatest impact.
• Fear-driven decisions, excessive supplements, and aggressive protocols rarely address the root issue and can do more harm than good.
• Tracking your cycle with OPK, BBT, and cervical mucus gives you real, actionable data. Premom can help you make sense of it.